Ethnic differences in hepatitis A and E virus seroprevalence in patients attending the Emergency Department, Paramaribo, Suriname

Trans R Soc Trop Med Hyg. 2023 Mar 1;117(3):197-204. doi: 10.1093/trstmh/trac101.

Abstract

Background: Hepatitis A virus (HAV) and hepatitis E virus (HEV) have enteric modes of transmission and are common causes of acute hepatitis in low- and middle-income countries. HEV is also characterised as a zoonotic infection and is prevalent in high-income countries. Data on HAV and HEV prevalence in Suriname, a middle-income country in South America, are scarce.

Methods: Serum samples of 944 and 949 randomly selected patients attending the Emergency Department at the Academic Hospital of Paramaribo, the capital of Suriname, were analysed for anti-HAV antibodies (anti-HAV) and anti-HEV antibodies (anti-HEV), respectively. Determinants of anti-HAV and anti-HEV positive serology were evaluated using multivariable logistic regression.

Results: Anti-HAV prevalence was 58.3% (95% CI 55.4 to 61.4%) and higher prevalence was independently associated with belonging to the Tribal or Indigenous population and older age. Anti-HEV prevalence was 3.7% (95% CI 2.6 to 5.0%) and higher prevalence was associated with Tribal and Creole ethnicity and older age.

Conclusions: In Suriname, exposure to HAV is consistent with a very low endemic country and exposure to HEV was rare. Both viruses were more prevalent in specific ethnic groups. As anti-HAVantibodies were less frequently found in younger individuals, they could be susceptible to potential HAV outbreaks and might require HAV vaccination.

Keywords: Suriname; epidemiology; hepatitis A virus; hepatitis E virus; indigenous population; multiethnic population; tribal population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Emergency Service, Hospital
  • Hepatitis A Antibodies
  • Hepatitis A virus*
  • Hepatitis A* / epidemiology
  • Hepatitis Antibodies
  • Hepatitis E virus*
  • Hepatitis E* / epidemiology
  • Humans
  • Prevalence
  • Seroepidemiologic Studies
  • Suriname

Substances

  • Hepatitis A Antibodies
  • Hepatitis Antibodies